Metoprolol Al

Metoprolol tartrate, the active ingredient in Metoprolol Al, is a beta‑adrenergic blocker presented as an oral tablet for oral use. It lowers blood pressure, relieves angina, and improves outcomes after myocardial infarction and in chronic heart failure. It is indicated for the management of hypertension, angina pectoris, post‑myocardial infarction care, chronic heart failure and selected cardiac arrhythmias, and is prescribed by physicians based on individual patient needs.

GNH USA supplies Metoprolol Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable logistics.

Metoprolol Al, a selective β1‑adrenergic blocker, is used in several cardiovascular conditions.

- Hypertension: reduces systolic and diastolic pressure by decreasing heart rate and cardiac output. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Post‑myocardial infarction: improves survival and reduces risk of recurrent events. - Chronic heart failure: enhances left‑ventricular function and reduces hospitalization. - Cardiac arrhythmias: controls ventricular rate in atrial fibrillation and other tachyarrhythmias.

Metoprolol Al may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Fatigue - Dizziness - Bradycardia - Cold extremities - Gastrointestinal upset - Headache

Serious or Rare Side Effects: - Severe bradycardia - Heart block - Bronchospasm - Hypotension - Allergic reactions - Depression

When prescribing Metoprolol Al, clinicians should observe several safety considerations.

- Monitor blood pressure: ensure target levels are achieved without excessive hypotension. - Assess heart rate: watch for bradycardia, especially in patients with conduction disorders. - Use caution in asthma or chronic obstructive pulmonary disease: β1 selectivity may still affect bronchial tone. - Avoid abrupt discontinuation: taper dose to prevent rebound hypertension or tachycardia. - Adjust dose in renal impairment: reduced clearance may increase drug exposure. - Store below 25°C: keep in the original pack, protect from moisture.

Metoprolol Al can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Non‑selective beta blockers (e.g., propranolol): additive β‑blockade may cause profound bradycardia. - Calcium channel blockers verapamil or diltiazem: combined effect on cardiac conduction can lead to heart block. - Clonidine: concurrent use may precipitate severe hypertension if clonidine is withdrawn abruptly.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may enhance hypotensive effect. - Diuretics: can increase risk of electrolyte imbalance and hypotension. - NSAIDs: may reduce antihypertensive efficacy of metoprolol.